Fibromodulin belongs to the family of small, leucine-rich proteoglycans which have been reported tointeract with collagens and to inhibit type I collagen fibrillogenesis. Decorin and fibromodulin exhibit anoticeable degree of sequence similarity. However, as previously reported [Font, B., Eichenberger, D.,Rosenberg, L. M. & van der Rest, M. (1996) Matrix Biol. 15,3412348] the domains of these moleculesimplicated in the interactions with type XII and type XIV collagens are different, these being the dermatansulphate/chondroitin sulphate chain for decorin and the core protein for fibromodulin. At the present timethe fibromodulin domains implicated in the interactions with fibrillar collagens remain unknown. Inexperiments reported here, we have sought to identify the structural requirements for fibromodulin in-teraction with collagen and for the control of type I collagen fibrillogenesis. Circular dichroism spectraand fibrillogenesis inhibition studies show that fibromodulin structure and its collagen fibrillogenesiscontrol function are strictly dependent on the presence of intact disulphide bridge(s). In addition, weshow that the binding of fibromodulin (or fibromodulin-derived fragments) to type I collagen is notnecessarily correlated with fibrillogenesis inhibition. To isolate fibromodulin domains, the native proteog-lycan was submitted to mild proteolysis. We have isolated an A-chymotrypsin2resistant fragment whichcontains the bulk of the N-terminal and central region of the molecule including the leucine-rich repeats4 and 6 reported for decorin to be involved in type I collagen binding. This fragment does not bind totype I collagen. Using enzymes with different specificities, a number of large fragments of fibromodulinwere obtained, suggesting a compact structure for this molecule which is relatively resistant to proteolysis.None of these N-glycosylated fragments were able to bind to type I collagen in co-sedimentation experi-ments. Taken together these results suggest that fibromodulin-type I collagen interactions leading tofibrillogenesis inhibition require more than one binding domain. One of these domains could be the C-terminal end of the molecule containing the disulphide loop which is absent in the chymotrypsin-resistantfragment.Keywords: collagen fibrillogenesis; fibromodulin; proteoglycan domain.In connective tissues, proteoglycans play important roles due cysteine residues, with at least one disulphide bridge, (b) ato their interactions with other components of the extracellular central region with a variable number (10212) of asparagine-matrix [1]. Among proteoglycans, several members of this group containing leucine-rich repeats containing N-linked keratan sul-are structurally related and constitute the small proteoglycan phate (fibromodulin and lumican) or N-linked oligosaccharidesfamily, namely biglycan, decorin, fibromodulin and lumican [2]. (biglycan and decorin) distributed among up to five potentialThese molecules are characterised by a core protein of about sites; and (c) a C-terminal region with a conserved disulphide40 kDa, and by the existence of three distinct regions: (a) a neg- loop.In vivo, small proteoglycans have been shown to associateatively charged N-terminal region with either covalently linked with fibrillar collagens [3]. In recent experiments, it has beendermatan sulphate/chondroitin sulphate (DS/CS) chains (usually reported that targeted disruption of the decorin gene in miceone in decorin and two in biglycan), or tyrosine sulphate in fi- leads to skin with markedly reduced tensile strength and to ab-bromodulin and lumican, and a highly conserved cluster of four normal morphology of collagen fibrils, indicating that in vivodecorin plays a major role in the regulation of fibril formation